Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism

References

• Sarvizadeh M, Ghasemi F, Tavakoli F, et al. Vaccines for colorectal cancer: an update. J Cell Biochem. 2019;120:8815–8828.
   PubMed Web of Science ®Google Scholar
• Berretta M, Cappellani A, Fiorica F, et al. FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study. Arch Gerontol Geriatr. 2011;52:89–93.
   PubMed Web of Science ®Google Scholar
• Berretta M, Nasti G, De Diviitis C, et al. Safety and efficacy of oxaliplatin-based chemotherapy in the first line treatment of elderly patients affected by metastatic colorectal cancer. WCRJ. 2014;1:e235.
   Google Scholar
• Weitz J, Koch M, Debus J, et al. Colorectal cancer. Lancet. 2005;365:153–165.
   PubMed Web of Science ®Google Scholar
• Nappi A, Berretta M, Romano1 C, et al. Metastatic colorectal cancer: role of target therapies and future perspectives. Current Cancer Drug Targets. 2017;17:1–9.
   Google Scholar
• Hartshorn CM, Russell LM, Grodzinski P. National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11:e1570.
   PubMed Web of Science ®Google Scholar
• Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003;2:347–360.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Al Zaki A, Hui JZ, et al. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science. 2012;338:903–910.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yan Z, Zhong J, et al. Peptide-mediated nano drug delivery system for tumor targeting. Prog Che. 2013;25:1052–1060.
   Web of Science ®Google Scholar
• Johnson MS, Lu N, Denessiouk K, et al. Integrins during evolution: evolutionary trees and model organisms. Biochim Biophys Acta. 2009;1788:779–789.
   PubMed Web of Science ®Google Scholar
• He S, Cen B, Liao L, et al. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. Drug Deliv. 2017;24:471–481.
   PubMed Web of Science ®Google Scholar
• Zeltz C, Primac I, Erusappan P, et al. Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins. Semin Cancer Biol. 2020;62:166–181.
   PubMed Web of Science ®Google Scholar
• Gladson CL, Cheresh DA. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest. 1991;88:1924–1932.
   PubMed Web of Science ®Google Scholar
• Seftor RE, Seftor EA, Gehlsen KR, et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A. 1992;89:1557–1561.
   PubMed Web of Science ®Google Scholar
• McQuade P, KnIght LC. Radiopharmaceuticals for targeting the angiogenesis marker alpha(v)beta(3). Q J Nucl Med. 2003;47:209–220.
   PubMedGoogle Scholar
• Chen X, Sievers E, Hou Y, et al. Integrin alpha v beta 3-targeted imaging of lung cancer . Neoplasia. 2005;7:271–279.
   PubMed Web of Science ®Google Scholar
• Sato T, Konishi K, Maeda K, et al. Integrin alpha v, c-erbB2 and DNA ploidy in lung metastases from colorectal cancer. Hepatogastroenterology. 2003;50:27–30.
   PubMedGoogle Scholar
• Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697–715.
   PubMed Web of Science ®Google Scholar
• Alipour M, Baneshi M, Hosseinkhani S, et al. Recent progress in biomedical applications of RGD-based ligand: From precise cancer theranostics to biomaterial engineering: a systematic review. J Biomed Mater Res A. 2020;108:839–850.
   PubMed Web of Science ®Google Scholar
• Dijkgraaf I, Beer AJ, Wester HJ. Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. Front Biosci (Landmark Ed). 2009;14:887–899.
   PubMed Web of Science ®Google Scholar
• Pike DB, Ghandehari H. HPMA copolymer-cyclic RGD conjugates for tumor targeting. Adv Drug Deliv Rev. 2010;62:167–183.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol. 2010;188:759–768.
   PubMed Web of Science ®Google Scholar
• Chen K, Chen X. Integrin targeted delivery of chemotherapeutics. Theranostics. 2011;1:189–200.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang L, Li L, et al. A novel dendrimer-based complex co-modified with cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment. Drug Deliv. 2019;26:989–1001.
   PubMed Web of Science ®Google Scholar
• Kim MS, Lee DW, Park K, et al. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Colloids Surf B Biointerfaces. 2014;116:17–25.
   PubMed Web of Science ®Google Scholar
• Yu KF, Zhang WQ, Luo LM, et al. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation. Int J Nanomedicine. 2013;8:2473–2485.
   PubMed Web of Science ®Google Scholar
• Bardania H, Shojaosadati SA, Kobarfard F, et al. Encapsulation of eptifibatide in RGD-modified nanoliposomes improves platelet aggregation inhibitory activity. J Thromb Thrombolysis. 2017;43:184–193.
   PubMed Web of Science ®Google Scholar
• Bardania H, Shojaosadati SA, Kobarfard F, et al. RGD-modified nano-liposomes encapsulated eptifibatide with proper hemocompatibility and cytotoxicity effect. Iran J Biotechnol. 2019;17:e2008.
   PubMed Web of Science ®Google Scholar
• Flament J, Geffroy F, Medina C, et al. In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7 T. Magn Reson Med. 2013;69:179–187.
   PubMed Web of Science ®Google Scholar
• Ferrauto G, Tripepi M, Di Gregorio E, et al. Detection of U-87 tumor cells by RGD-functionalized/Gd-containing giant unilamellar vesicles in magnetization transfer contrast magnetic resonance images. Invest Radiol. 2020.
   PubMed Web of Science ®Google Scholar
• Rizvi SFA, Mu S, Wang Y, et al. Fluorescent RGD-based pro-apoptotic peptide conjugates as mitochondria-targeting probes for enhanced anticancer activities. Biomed Pharmacother. 2020;127:110179.
   PubMed Web of Science ®Google Scholar
• Vellai T. Autophagy genes and ageing. Cell Death Differ. 2009;16:94–102.
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112:1809–1820.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Hara T. Intracellular quality control by autophagy: how does autophagy prevent neurodegeneration? Autophagy. 2006;2:302–304.
   PubMed Web of Science ®Google Scholar
• Liao X, Sluimer JC, Wang Y, et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 2012;15:545–553.
   PubMed Web of Science ®Google Scholar
• Ost A, Svensson K, Ruishalme I, et al. Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med. 2010;16:235–246.
   PubMed Web of Science ®Google Scholar
• White E, Karp C, Strohecker AM, et al. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol. 2010;22:212–217.
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Zalckvar E, Kimchi A, et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741–752.
   PubMed Web of Science ®Google Scholar
• Harhaji L, Isakovic A, Raicevic N, et al. Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. Eur J Pharmacol. 2007;568:89–98.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yang W, Man N, et al. Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal. Autophagy. 2009;5:1107–1117.
   PubMed Web of Science ®Google Scholar
• Wei P, Zhang L, Lu Y, et al. C60(Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy. Nanotechnology. 2010;21:495101.
   PubMed Web of Science ®Google Scholar
• Li H, Li Y, Jiao J, et al. Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat Nanotechnol. 2011;6:645–650.
   PubMed Web of Science ®Google Scholar
• Wu YN, Yang LX, Shi XY, et al. The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondria-mediated autophagy. Biomaterials. 2011;32:4565–4573.
   PubMed Web of Science ®Google Scholar
• Yokoyama T, Tam J, Kuroda S, et al. EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. PLoS One. 2011;6:e25507.
   PubMed Web of Science ®Google Scholar
• Joshi P, Chakraborti S, Ramirez-Vick JE, et al. The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells. Colloids Surf B Biointerfaces. 2012;95:195–200.
   PubMed Web of Science ®Google Scholar
• Khan MI, Mohammad A, Patil G, et al. Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials. 2012;33:1477–1488.
   PubMed Web of Science ®Google Scholar
• Haran G, Cohen R, Bar LK, et al. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta. 1993;1151:201–215.
   PubMed Web of Science ®Google Scholar
• Li Y, Lei Y, Wagner E, et al. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells. Bioconjug Chem. 2013;24:133–143.
   PubMed Web of Science ®Google Scholar
• Pan Y, He B, Lirong Z, et al. Gene therapy for cancer through adenovirus vector-mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting . Oncol Rep. 2013;30:1814–1822.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Syed GH, Siddiqui A. Hepatitis C virus induces the mitochondrial translocation of Parkin and subsequent mitophagy. PLoS Pathog. 2013;9:e1003285.
   PubMed Web of Science ®Google Scholar
• Li J, Xu X, Jiang Y, et al. Elastin is a key factor of tumor development in colorectal cancer. MC Cancer. 2020;20:217.
   PubMed Web of Science ®Google Scholar
• Chen D, Lian S, Sun J, et al. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Drug Deliv. 2016;23:808–813.
   PubMed Web of Science ®Google Scholar
• do Nascimento T, Todeschini AR, Santos-Oliveira R, et al. Trends in nanomedicines for cancer treatment. Curr Pharm Des. 2020;26:3579–3600.
   PubMed Web of Science ®Google Scholar
• Ruman U, Fakurazi S, Masarudin MJ, et al. Nanocarrier-based therapeutics and theranostics drug delivery systems for next generation of liver cancer nanodrug modalities. Int J Nanomedicine. 2020;15:1437–1456.
   PubMed Web of Science ®Google Scholar
• Zare M, Norouzi Roshan ZN, Assadpour E, et al. Improving the cancer prevention/treatment role of carotenoids through various nano-delivery systems. Crit Rev Food Sci Nutr. 2021;61:522–534.
   PubMed Web of Science ®Google Scholar
• Wei Y, Xu S, Wang F, et al. A novel combined micellar system of lapatinib and paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro. J Pharm Sci. 2015;104:165–177.
   PubMed Web of Science ®Google Scholar
• Liu J, Shapiro JI. Endocytosis and signal transduction: basic science update. Biol Res Nurs. 2003;5:117–128.
   PubMedGoogle Scholar
• Xin H, Jiang X, Gu J, et al. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials. 2011; 32:4293–4305.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Guan J, Jiang Z, et al. Brain-targeted drug delivery by manipulating protein corona functions. Nat Commun. 2019;10:3561.
   PubMed Web of Science ®Google Scholar
• Düzgüne&Scedil N, Nir S. Mechanisms and kinetics of liposome-cell interactions. Adv Drug Deliv Rev. 1999;40:3–18.
   Google Scholar
• Sun Y, Yan X, Yuan T, et al. Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin. Biomaterials. 2010;31:7124–7131.
   PubMed Web of Science ®Google Scholar
• Gallo S, Spilinga M, Albano R, et al. Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro. Br J Pharmacol. 2020;177:3107–3122.
   PubMed Web of Science ®Google Scholar